UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGIO
2401
DELISTED
Edgio, Inc. Common Stock
EGIO
| $176K | ﹤0.01% |
3,902
| – | – |
|
2402
Hagerty
HGTY
$1.39B
| $175K | ﹤0.01% |
20,855
| – | – |
|
2403
Phibro Animal Health
PAHC
$1.39B
| $175K | ﹤0.01% |
13,078
| – | – |
|
2404
1-800-Flowers.com
FLWS
$258M
| $173K | ﹤0.01% |
18,107
| – | – |
|
2405
C4 Therapeutics
CCCC
$412M
| $173K | ﹤0.01% |
+29,293
| New | +$243K |
|
2406
Amneal Pharmaceuticals
AMRX
$5.79B
| $169K | ﹤0.01% |
84,912
| – | – |
|
2407
FuboTV Inc
FUBO
$273M
| $169K | ﹤0.01% |
8,073
| – | – |
|
2408
AtaiBeckley Inc
ATAI
$2.68B
| $168K | ﹤0.01% |
63,211
+20,642
| +48% | +$62.7K |
|
2409
Rackspace Technology
RXT
$1.24B
| $166K | ﹤0.01% |
56,149
| – | – |
|
2410
Holley
HLLY
$384M
| $162K | ﹤0.01% |
76,593
+19,919
| +35% | +$62.7K |
|
2411
Vital Farms
VITL
$525M
| $161K | ﹤0.01% |
10,768
| – | – |
|
2412
Cellebrite
CLBT
$3.99B
| $159K | ﹤0.01% |
36,400
| – | – |
|
|
NGM
2413
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $158K | ﹤0.01% |
31,431
+664
| +2% | +$4.16K |
|
|
BASE
2414
DELISTED
Couchbase
BASE
| $157K | ﹤0.01% |
+11,827
| New | +$153K |
|
2415
Comtech Telecommunications
CMTL
$51.8M
| $157K | ﹤0.01% |
12,892
| – | – |
|
2416
Ranpak Holdings
PACK
$473M
| $152K | ﹤0.01% |
26,426
-13,117
| -33% | -$62.7K |
|
2417
Kodak
KODK
$983M
| $152K | ﹤0.01% |
49,937
| – | – |
|
|
BLUE
2418
DELISTED
bluebird bio
BLUE
| $150K | ﹤0.01% |
+1,085
| New | +$153K |
|
2419
Bioventus
BVS
$1.19B
| $145K | ﹤0.01% |
+55,511
| New | +$242K |
|
2420
Quantum-Si Incorporated
QSI
$177M
| $143K | ﹤0.01% |
77,937
+20,537
| +36% | +$52.9K |
|
2421
Dyne Therapeutics
DYN
$4.9B
| $142K | ﹤0.01% |
12,222
| – | – |
|
2422
ESS Tech
GWH
$18.9M
| $140K | ﹤0.01% |
3,852
| – | – |
|
2423
SES AI
SES
$208M
| $136K | ﹤0.01% |
43,234
-46,074
| -52% | -$223K |
|
2424
El Pollo Loco
LOCO
$462M
| $130K | ﹤0.01% |
13,062
| – | – |
|
2425
Energy Vault
NRGV
$633M
| $128K | ﹤0.01% |
40,874
| – | – |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.